JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB17127

Anti-ALK 抗体 [5A4]

Anti-ALK antibody [5A4]

Be the first to review this product! Submit a review

|

(24 Publications)

Anti-ALK antibody [5A4] (ab17127) is a mouse monoclonal antibody detecting ALK in IHC-P. Suitable for Human.

- Over 20 publications
- Trusted since 2005

查看别名

CD246, ALK tyrosine kinase receptor, Anaplastic lymphoma kinase, ALK

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ALK antibody [5A4] (AB17127)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ALK antibody [5A4] (AB17127)

Immunohistochemical analysis of formalin-fixed, paraffin-embedded human anaplastic lymphoma tissue, staining ALK with ab17127.

关键信息

宿主种属

Mouse

克隆

Monoclonal

克隆号

5A4

亚型

IgG1

不含载体蛋白

No

反应种属

Human

应用

IHC-P

applications

免疫原

Recombinant Fragment Protein within Human ALK aa 400-550. The exact immunogen used to generate this antibody is proprietary information.

Q9UM73

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/25.00000 - 1/70.00000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol." } } }

您可能对以下产品感兴趣:

AB283550

Human ALK ELISA Kit

0

0 Reviews

查看产品
为什么推荐这个?

我们推荐这个产品,因为它经常被用于相同的实验或相关的研究。

我们建议您务必查阅产品说明书,以确认其是否符合您的实验需求;若有疑问,也可联系我们的技术团队获取协助。

产品详情

What is this antibody validated in?
Anti-ALK antibody [5A4] (ab17127) is a mouse monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human samples.

Trusted by the scientific community
Anti-ALK [5A4] (ab17127) was first used in a scientific publication in 2005 and has been cited over 20 times in peer-reviewed journals.

性能和储存信息

形式
Liquid
纯度
Tissue culture supernatant
存储溶液
pH: 7.3 - 7.5 Preservative: 0.05% Sodium azide Constituents: Tissue culture supernatant, 1% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

The Anaplastic Lymphoma Kinase commonly referred to as ALK is a receptor tyrosine kinase known for its role in cell signaling. It is sometimes called CD246. ALK has a molecular mass of approximately 180 kDa. This protein finds expression predominantly in the central and peripheral nervous system with prominence in neural tissue during development. The ALK protein belongs to the insulin receptor superfamily exhibiting kinase activity that promotes signal transduction processes associated with growth and differentiation.
Biological function summary

ALK influences cell growth survival and differentiation playing a significant role during the development of the nervous system. As part of its biological activity the ALK protein can become a component of larger signaling complexes participating as an important activator or mediator. Evidence suggests ALK's involvement in neuronal differentiation and synaptogenesis. Its activity impacts intracellular pathways consequently modulating biological processes relevant to neural tissue and oncogenesis.

Pathways

ALK acts within the MAPK and PI3K-AKT signaling pathways. These pathways enable the transduction of signals from the cell surface to the nucleus influencing cellular outcomes such as proliferation and survival. In these pathways ALK interacts with various other proteins including GRB2 and PI3K which further facilitate downstream signaling. Proper functioning of these pathways is essential to maintaining cellular homeostasis and development.

ALK has a significant relationship with certain types of cancer such as non-small cell lung carcinoma and anaplastic large cell lymphoma. Genetic alterations in ALK such as translocations or mutations can lead to the uncontrolled activation of its kinase activity resulting in oncogenic transformation. In these contexts the ALK protein often interacts with EML4 in lung cancer through a fusion forming an oncogenic driver. Targeting ALK with anti-ALK antibodies or small molecule inhibitors has emerged as a therapeutic strategy to manage these malignancies.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system (PubMed : 11121404, PubMed : 11387242, PubMed : 16317043, PubMed : 17274988, PubMed : 30061385, PubMed : 34646012, PubMed : 34819673). Also acts as a key thinness protein involved in the resistance to weight gain : in hypothalamic neurons, controls energy expenditure acting as a negative regulator of white adipose tissue lipolysis and sympathetic tone to fine-tune energy homeostasis (By similarity). Following activation by ALKAL2 ligand at the cell surface, transduces an extracellular signal into an intracellular response (PubMed : 30061385, PubMed : 33411331, PubMed : 34646012, PubMed : 34819673). In contrast, ALKAL1 is not a potent physiological ligand for ALK (PubMed : 34646012). Ligand-binding to the extracellular domain induces tyrosine kinase activation, leading to activation of the mitogen-activated protein kinase (MAPK) pathway (PubMed : 34819673). Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif (PubMed : 15226403, PubMed : 16878150). Induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1 (PubMed : 15226403, PubMed : 16878150). ALK activation may also be regulated by pleiotrophin (PTN) and midkine (MDK) (PubMed : 11278720, PubMed : 11809760, PubMed : 12107166, PubMed : 12122009). PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation (PubMed : 11278720, PubMed : 11809760, PubMed : 12107166). MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction (PubMed : 12122009). Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase (PubMed : 15226403, PubMed : 16878150). Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK (PubMed : 15226403, PubMed : 16878150).
See full target information ALK

文献 (24)

Recent publications for all applications. Explore the full list and refine your search

Applied immunohistochemistry & molecular morphology : AIMM 30:477-485 PubMed35876743

2022

Digital Image Analysis and Quantitative Bead Standards in Root Cause Analysis of Immunohistochemical Staining Variability: A Real-world Example.

Applications

Unspecified application

Species

Unspecified reactive species

Rebecca Rojansky,Seshi R Sompuram,Ellen Gomulia,Yasodha Natkunam,Megan L Troxell,Sebastian Fernandez-Pol

Methods in molecular biology (Clifton, N.J.) 2279:157-164 PubMed33683692

2021

Immunocytochemical Detection of ALK and ROS1 Rearrangements in Lung Cancer Cytological Samples.

Applications

Unspecified application

Species

Unspecified reactive species

Diane Frankel,Elise Kaspi,Patrice Roll

The American journal of surgical pathology 45:653-661 PubMed33399341

2021

Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 Cases.

Applications

Unspecified application

Species

Unspecified reactive species

Pedram Argani,Derrick W Q Lian,Abbas Agaimy,Markus Metzler,Sara E Wobker,Andres Matoso,Jonathan I Epstein,Yun-Shao Sung,Lei Zhang,Cristina R Antonescu

Pathology oncology research : POR 26:2795-2800 PubMed31407221

2019

Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Hussein Nassereddine,Aurélie Sannier,Solenn Brosseau,Jean-Michel Rodier,Antoine Khalil,Simon Msika,Claire Danel,Anne Couvelard,Nathalie Théou-Anton,Aurélie Cazes

Case reports in oncological medicine 2019:5064852 PubMed31485361

2019

Annexin A2 Expression in Aerogenous Metastasis of Pulmonary Invasive Mucinous Adenocarcinoma: A Case Report including Immunohistochemical Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Kazumori Arai,Masahide Hirose

Translational oncology 12:784-787 PubMed30909092

2019

Isolated 5' Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the Literature.

Applications

Unspecified application

Species

Unspecified reactive species

Alice Guyard,Cécile Charpy,Nathalie Théou-Anton,Anne Cremades,Frédéric Grassin,Anaïs Bourgogne,Karen Leroy,Anaïs Pujals,Christiane Copie-Bergman,Christos Chouaid,Audrey Mansuet-Lupo

Blood 131:1576-1586 PubMed29437595

2018

Integrated molecular profiling of juvenile myelomonocytic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Norihiro Murakami,Yusuke Okuno,Kenichi Yoshida,Yuichi Shiraishi,Genta Nagae,Kyogo Suzuki,Atsushi Narita,Hirotoshi Sakaguchi,Nozomu Kawashima,Xinan Wang,Yinyan Xu,Kenichi Chiba,Hiroko Tanaka,Asahito Hama,Masashi Sanada,Masafumi Ito,Masashi Hirayama,Arata Watanabe,Toshihide Ueno,Seiji Kojima,Hiroyuki Aburatani,Hiroyuki Mano,Satoru Miyano,Seishi Ogawa,Yoshiyuki Takahashi,Hideki Muramatsu

Journal of thoracic disease 9:S1359-S1363 PubMed29184674

2017

Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Alfredo Tartarone,Rosa Lerose,Maria Grazia Rodriquenz,Giuseppina Mambella,Giuseppe Calderoni,Giovanni Bozza,Michele Aieta

Journal of thoracic disease 9:S1391-S1396 PubMed29184678

2017

Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared.

Applications

Unspecified application

Species

Unspecified reactive species

Mariangela Manicone,Maria Chiara Scaini,Maria Grazia Rodriquenz,Antonella Facchinetti,Alfredo Tartarone,Michele Aieta,Rita Zamarchi,Elisabetta Rossi

Scientific reports 7:12510 PubMed28970558

2017

Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.

Applications

Unspecified application

Species

Unspecified reactive species

Julie A Vendrell,Sylvie Taviaux,Benoît Béganton,Sylvain Godreuil,Patricia Audran,David Grand,Estelle Clermont,Isabelle Serre,Vanessa Szablewski,Peter Coopman,Julien Mazières,Valérie Costes,Jean-Louis Pujol,Pierre Brousset,Isabelle Rouquette,Jérôme Solassol
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

关联产品

Select an associated product type
Alternative Product
Primary Antibodies

AB73996

Anti-ALK (phospho Y1507) antibody

primary-antibodies

alk-phospho-y1507-antibody-ab73996

0

(0 reviews)

Alternative Product
Primary Antibodies

AB74159

Anti-ALK antibody

primary-antibodies

alk-antibody-ab74159

3

(1 reviews)

Alternative Product
Primary Antibodies

AB139139

Anti-ALK (phospho Y1586) antibody

primary-antibodies

alk-phospho-y1586-antibody-ab139139

0

(0 reviews)

Alternative Product
Primary Antibodies

AB192809

Anti-ALK (phospho Y1507) antibody

primary-antibodies

alk-phospho-y1507-antibody-ab192809

0

(0 reviews)

Alternative Product
Primary Antibodies

AB190934

Anti-ALK antibody - C-terminal

primary-antibodies

alk-antibody-c-terminal-ab190934

0

(0 reviews)

Alternative Product
Primary Antibodies

AB16670

Anti-ALK antibody [SP8]

primary-antibodies

alk-antibody-sp8-ab16670

0

(0 reviews)

Alternative Product
Primary Antibodies

AB183332

Anti-ALK antibody [SP144]

primary-antibodies

alk-antibody-sp144-ab183332

0

(0 reviews)

Alternative Product
Primary Antibodies

AB271941

Anti-ALK antibody [SP144] - BSA and Azide free

primary-antibodies

alk-antibody-sp144-bsa-and-azide-free-ab271941

3

(1 reviews)

Alternative Product
Primary Antibodies

AB62185

Anti-ALK (phospho Y1604) antibody

primary-antibodies

alk-phospho-y1604-antibody-ab62185

4

(1 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com